Addition of Loncastuximab Tesirine to Acalbrutinib , Chronic Lymphocytic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Chronic Lymphocytic Leukemia
Related studies linked through entity extraction aliases.
A Clinical Trial on the Safety and Efficacy of TQB3909 Tablets in Patients With Recurrent or Refractory Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL) .
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Single Arm Study of Acalabrutinib Conbimed With Obinutuzumab in Chinese Patients With Previously Untreated CLL
- Status
- RECRUITING
- Phase
- NA
Tafasitamab, Acalabrutinib, and Obinutuzumab for the Treatment of Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
Multiple Myeloma/Chronic Lymphocytic Leukemia Coach RCT
- Status
- COMPLETED
- Phase
- NA
Determining Clinical Study Experiences of Chronic Lymphocytic Leukemia Patients
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
HEALTH4CLL2: A Randomized Waitlist Control Trial of Behavioral Interventions in Patients With Chronic Lymphocytic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Study Evaluating SC291 in Subjects With r/r B-cell Malignancies (ARDENT)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Biomarker for Infection Risk in CLL and MM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Incidence of Severe COVID-19 Infection in Patients With CLL or B-NHL Who Received Pre-exposure Prophylaxis With Tixagevimab and Cilgavimab in Italy.
- Status
- RECRUITING
- Phase
- N/A
Trial of Anti-CD19 and Anti-CD20 Bicistronic Chimeric Antigen Receptor T Cells for Treating B-Cell Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Safety and Efficacy of Allogenic CD19-CAR-NK Cells in Treatmenting r/r B-cell Hematologic Malignancies
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Familial B-cell Lymphoproliferative Disorders
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Tafasitamab and Zanubrutinib for the Treatment of Patients With Newly Diagnosed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, TaZA CLL Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Metabolically Fit CD19 CAR T-cell Therapy With CD34 Selection in Patients With CD19+ Relapsed/Refractory NHL, CLL/SLL
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Dose Escalation/Dose Expansion Study of PRGN-3007 UltraCAR-T Cells in Patients With Advanced Hematologic and Solid Tumor Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Ibrutinib for the Treatment of AIHA in Patients With CLL/SLL or CLL-like MBL
- Status
- RECRUITING
- Phase
- PHASE2
Pirtobrutinib and Venetoclax With MRD Detection for Previously Untreated Chronic Lymphocytic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia
- Status
- SUSPENDED
- Phase
- PHASE2
Implanted Loop Recorders for Detection and Management of Arrhythmia With Bruton Tyrosine Kinase Inhibitors
- Status
- RECRUITING
- Phase
- NA